Profile
AERI ZTS HLN TAK TEVA NBIX
Company Name Aerie Pharmaceuticals, Inc. Zoetis Inc. Haleon plc Takeda Pharmaceutical Company Limited Teva Pharmaceutical Industries Limited Neurocrine Biosciences, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic
Market Cap - $77.92B $43.25B $42.20B $20.24B $15.52B
Employees 0.38K 14.10K 25.41K 49.28K 37.00K 1.70K
CEO Dr. Vicente Anido Ms. Kristin C. Peck Mr. Brian James McNamara Mr. Christophe Weber Mr. Richard D. Francis Mr. Kyle W. Gano Ph.D.
Ratings
AERI ZTS HLN TAK TEVA NBIX
Quant Rating Score 3 3 3 3 1 4
Quant Rating Neutral Neutral Neutral Neutral Strong Sell Buy
Trading
AERI ZTS HLN TAK TEVA NBIX
Last Close $15.25 $172.71 $9.57 $13.7 $17.84 $153.29
High 52 $15.25 $199.94 $10.69 $15.08 $22.77 $153.29
Low 52 $15.25 $145.54 $8.01 $12.6 $12.01 $111.62
Price vs. 52 Week High 0 % -13.62 % -10.48 % -9.15 % -21.65 % 0 %
Price vs. 52 Week Low 0 % 18.67 % 19.48 % 8.73 % 48.54 % 37.33 %
Total Return
AERI ZTS HLN TAK TEVA NBIX
1 Month Return 0 % 6 % 0.31 % 3.47 % -19.06 % 12.3 %
3 Month Return 0 % -3.4 % -1.24 % -1.72 % -3.25 % 27.45 %
6 Month Return 0 % -4.07 % 4.59 % -1.3 % 2.35 % 8.28 %
9 Month Return 0 % 8.97 % 14.61 % 3.87 % 27.61 % 7.17 %
YTD Return 0 % 6 % 0.31 % 3.47 % -19.06 % 12.3 %
1 Year Return 0 % -8.04 % 16.71 % -6.16 % 47.44 % 9.67 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
AERI ZTS HLN TAK TEVA NBIX
Dividend Yield Percentage (TTM) - 1.04 % 1.65 % 4.59 % - -
Dividend Paid and Capex Coverage Ration (TTM) -30.13 % 2.1 % - 1.34 % 3.8 % 13.12 %
Dividend Per Share (TTM) - 1.8 % 0.06 % 192 % - -
Payout Ratio (TTM) - 31.44 % - 101.62 % - -
Growth
AERI ZTS HLN TAK TEVA NBIX
Asset Growth 7.3 % -4.28 % -2.18 % 8.25 % -1.2 % 37.27 %
Gross Profit Growth 189.4 % 3.7 % 5.84 % 1.76 % 9.65 % 26.06 %
Revenue Growth 133.51 % 5.74 % 4.09 % 5.87 % 6.17 % 26.76 %
Revenue 3 Year 621.88 % 31.98 % 13.9 % 33.13 % -6.91 % 71.93 %
Revenue 5 Year - 53.64 % 32.87 % 103.83 % -23.33 % 308.36 %
Revenue 10 Year - 103.1 % 32.87 % 152.69 % -40.82 % 44100.16 %
EBIT Growth 70.9 % 6.27 % 9.37 % -56.36 % -84.52 % 0.76 %
Net Income Growth 59.14 % 10.88 % -1.04 % -54.56 % 76.24 % 61.62 %
Net Income 3 Yeari Growth Per Share 71.08 % 47.55 % -8.67 % -61.74 % 86.29 % -41.58 %
Net Income 5 Yeari Growth Per Share 52.51 % 71.94 % 59.66 % 32.36 % 76.28 % 1054.95 %
Net Income 10 Yeari Growth Per Share -97.3 % 404.24 % 59.66 % 35.42 % -133.42 % 470.4 %
Operating Income Growth 70.9 % 6.27 % 9.37 % -56.36 % -84.52 % 0.76 %
Operating Cash Flow Growth (CFG) -53.28 % 23.06 % 1.79 % -26.69 % -13.96 % 14.88 %
Operating 3 Year CFG 41.57 % 14.12 % 48.8 % -29.25 % 10.09 % 62.6 %
Operating 5 Year CFG 21.91 % 37.69 % 166.36 % 118.64 % -48.98 % 275.6 %
Operating 10 Year CFG -182.62 % 274.61 % 166.36 % 384.17 % -67.94 % 1000.37 %
EPS Growth 59.65 % 12.64 % - -54.92 % 76.42 % 59.01 %
EPS Diluted Growth 59.65 % 12.92 % - -54.86 % 76.42 % 58.33 %
Book Value Per Share -171.63 % 15.25 % 1.35 % 13.54 % -7.25 % 28.15 %
Share Holder 3 Year Equity Growth Per Share -106.84 % 36.7 % -36.6 % 40.38 % -26.74 % 88.86 %
Share Holder 5 Year Equity Growth Per Share -110.35 % 139.55 % -39.41 % 41.33 % -53.44 % 353.33 %
Share Holder 10 Year Equity Growth Per Share -150.88 % 476.36 % -39.41 % 195.14 % -74.76 % 1167.34 %
Dividend Per Share Growth - 15.15 % -85.58 % 1.95 % - -
Dividend 3 Year Growth Per Share - 87.76 % -83.69 % 1.19 % - -
Dividend 5 Year Growth Per Share - 198.29 % -66.42 % 101.42 % -100 % -
Dividend 10 Year Growth Per Share - 665.58 % -66.42 % 102.58 % -100 % -
Debt Growth 21.06 % -16.5 % -9.43 % 10.53 % -6.53 % 62.95 %
Free Cash Flow Growth -51.12 % 22.25 % 1.67 % -31.4 % -19.19 % 11.99 %
Updated On 31 Dec 2021 31 Dec 2023 31 Dec 2023 31 Mar 2024 31 Dec 2023 31 Dec 2023
Profitability
AERI ZTS HLN TAK TEVA NBIX
Gross Profit Margin TTM 86.17 % 68.87 % 60.68 % 55.23 % 49.84 % 98 %
Return on Assets TTM -17.34 % 16.93 % 3.26 % 1.99 % -2.38 % 10.92 %
Return on Equity TTM -2255.01 % 47.99 % 6.54 % 4.04 % -14.6 % 15.68 %
Return on Capital Employed TTM -14.79 % 26.36 % 7.22 % 4.18 % 1.6 % 18.91 %
Net Income Per EBT TTM 100.8 % 79.65 % 65.38 % 108.74 % 176.38 % 73.98 %
EBT Per Ebit TTM 163.79 % 91.46 % 82.95 % 52.35 % -125.67 % 88.81 %
EBIT Per Revenue TTM -23.34 % 36.45 % 17.82 % 11.21 % 2.67 % 26.19 %
Cash Flow To Debt Ratio TTM -38.04 % 43.6 % - 16.58 % 9.63 % 189.5 %
Receivables Turnover TTM 1.22 6.49 5.27 6.3 4.84 4.66
Payables Turnover TTM 3.24 7.05 1.23 4.92 3.55 0.47
Inventory Turnover TTM 0.66 1.18 3.03 1.69 2.12 0.98
Fixed Asset Turnover TTM 261.84 % 259.93 % 604.62 % 240.84 % 277.85 % 664.93 %
Asset Turnover TTM 45 % 63.75 % 33.71 % 31.2 % 40.16 % 63.45 %
Operating Cash Flow Per Share TTM -2.14 6.5 - 528.88 1.64 4.71
Free Cash Flow Per Share TTM -2.21 5.1 - 321.24 1.21 4.35
Cash Per Share TTM 301.71 % 378.45 % 5.72 % 57241.03 % 292.94 % 1214.64 %
Operating Cash Flow Sales Ratio TTM -51.08 % 32.18 % - 18.42 % 11.07 % 21.24 %
Free Cash Flow Operating Cash Flow Ratio TTM 103.32 % 78.37 % - 60.74 % 73.71 % 92.38 %
Cash Flow Coverage Ratios TTM -38.04 % 43.6 % - 16.58 % 9.63 % 189.5 %
Price To Free Cash Flows Ratio TTM - 33.76 - 13.03 14.86 35.27
Price To Operating Cash Flows Ratio TTM -7.13 26.56 - 7.9 10.94 32.53
Price Cash Flow Ratio TTM -7.13 26.56 - 7.9 10.94 32.53
Income Statement (TTM)
AERI ZTS HLN TAK TEVA NBIX
Revenue $0.19B $8.54B $11.3B $4263.76B $16.54B $1.89B
Gross Profit $0.17B $5.83B $6.96B $2832.26B $8.06B $1.85B
Gross Profit Ratio 86.17% 68.28% 61.59% 66.43% 48.74% 97.9%
EBITDA $-0.01B $3.69B $2.35B $874.6B $-0.3B $0.36B
Net Income $-0.07B $2.34B $1.05B $144.07B $-1.64B $0.25B
EPS Diluted -1.61 5.07 0.11 91.16 -1.43 2.47
Balance Sheet (MRQ)
AERI ZTS HLN TAK TEVA NBIX
Long Term Debt $0.26B $6.75B $8.8B $5029.93B $18.48B $0.26B
Total Liabilities $0.45B $9.3B $17.33B $7834.79B $35.35B $1.02B
Total Equity $-0.02B $4.99B $16.73B $7274.01B $8.13B $2.23B
Total Investments $0.1B $0.02B $0.07B $445.7B $0.01B $1.63B
Total Debt $0.26B $6.76B $9.46B $4843.75B $20.15B $0.43B
Total Assets $0.43B $14.29B $34.06B $15108.79B $43.48B $3.25B
Cash Flow Statement (TTM)
AERI ZTS HLN TAK TEVA NBIX
Net Income $-0.07B $2.34B $1.11B $144.07B $-1.96B $0.25B
Inventory $-0.01B $-0.36B $-0.13B $-115.74B $0B $0.01B
Dividends Paid $0B $-0.69B $-0.39B $-287.19B $0B $0B
Operating Cash Flow $-0.1B $2.35B $2.1B $716.34B $1.25B $0.39B
Capital Expenditure $-0B $-0.73B $-0.34B $-480.73B $-0.5B $-0.03B
Related Stocks
Ticker Name Price
ACB Aurora Cannabis Inc. 3.82
ACOR Acorda Therapeutics, Inc. 0.661
ACRX AcelRx Pharmaceuticals, Inc. 0.86
ADMP Adamis Pharmaceuticals Corporation 0.775
ADMS Adamas Pharmaceuticals, Inc. 8.22
AGRX Agile Therapeutics, Inc. 1.51
AKAN Akanda Corp. 1.57
ALIM Alimera Sciences, Inc. 5.54
ALVO Alvotech 12.41
ALVOW Alvotech 2.48
AMPH Amphastar Pharmaceuticals, Inc. 36.37
AMRX Amneal Pharmaceuticals, Inc. 8.58
AMYT Amryt Pharma plc 14.7
ANIP ANI Pharmaceuticals, Inc. 59.56
AQST Aquestive Therapeutics, Inc. 3.08
ASRT Assertio Holdings, Inc. 0.8255
ATNX Athenex, Inc. 0.2031
AVDL Avadel Pharmaceuticals plc 7.69
AYTU Aytu BioPharma, Inc. 1.68
BDSI BioDelivery Sciences International, Inc. 5.59
ETFs With Exposure to AERI
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.03 228.53
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 133.21
IWN iShares Russell 2000 Value ETF 0.01 169.03
IWV iShares Russell 3000 ETF 0 346.54
IWO iShares Russell 2000 Growth ETF 0.05 299.67
VHT Vanguard Health Care Index Fund 0 271.78
BIB ProShares Ultra Nasdaq Biotechnology 0.03 56.01
HDG ProShares Hedge Replication ETF 0 50.0408
UWM ProShares Ultra Russell2000 0.01 44.54
IWC iShares Micro-Cap ETF 0.17 131.279
FHLC Fidelity MSCI Health Care Index ETF 0.01 70.03
URTY ProShares UltraPro Russell2000 0.01 53.6
BTEC Principal Healthcare Innovators ETF 0.21 39.49
GSSC Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF 0.14 71.71
IHE iShares U.S. Pharmaceuticals ETF 0.3 70.2
AGNG Global X Aging Population ETF 0.6 31.95
PBSM Invesco PureBeta MSCI USA Small Cap ETF 0.02 31.9152
PSC Principal U.S. Small-Cap Multi-Factor ETF 0.06 53.97
VTWG Vanguard Russell 2000 Growth Index Fund 0.02 218.45
VSTCX Vanguard Strategic Small-Cap Equity Fund Investor Shares 0.05 41.14
SPGM SPDR Portfolio MSCI Global Stock Market ETF 0.01 65.64
MARB First Trust Vivaldi Merger Arbitrage ETF 1.46 19.783
IEIH iShares Evolved U.S. Innovative Healthcare ETF 0.03 34.1348
RYLD Global X Russell 2000 Covered Call ETF 0.03 16.64
AVUS Avantis U.S. Equity ETF 0 101.07
IBBQ Invesco Nasdaq Biotechnology ETF 0.07 22.65
JFWD Jacob Forward ETF 2.66 11.8807
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.07 6.5925
WSML.L iShares MSCI World Small Cap UCITS ETF 0.01 7.867
AGED.L iShares Ageing Population UCITS ETF 0.09 8.0175
QQQS Invesco NASDAQ Future Gen 200 ETF 0.53 29.3142
IUSN.DE iShares MSCI World Small Cap UCITS ETF 0.01 7.548
SXRG.DE iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced UCITS ETF USD (Acc) 0.03 538.6
VEXPX Vanguard Explorer Fd 0 120.99
WLDS.L iShares MSCI World Small Cap UCITS ETF 0.01 6.315
VHCIX Vanguard HealthCare Index Fund Admiral Shs 0 136.08
JKK iShares Morningstar Small-Cap Growth ETF 0.02 307.42
JKJ iShares Morningstar Small-Cap ETF 0.01 231.193
LNGR Global X Aging Population ETF 0.6 27.75
JKL iShares Morningstar Small-Cap Value ETF 0.01 172.726
Unlock